Horizon Discovery Group (HZD)

 

HZD Share PerformanceMore

52 week high188.05 29/04/16
52 week low104.00 30/11/16
52 week change 21.50 (14.58%)
4 week volume3,966,428 28/01/17

Media for (HZD)

Presenter: Dr Darrin Disley
12/10/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Site Visit

RNS Number: 6123X Horizon Discovery Group plc 23 February 2017 Horizon Discovery ("Horizon" or the "Group") Site Visit Cambridge, UK, 23 February 2017: Horizon Discovery Group plc (LSE: HZD), the world leader in the application of gene editing technologies, is hosting a site visit at its corporate headquarters for institutional investors today and for sell-side a...

Holding(s) in Company

RNS Number: 3275X Horizon Discovery Group plc 20 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Horizon Discovery Group Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of vo...

Neil Woodford’s seven trades in January

After a poor 2016, star fund manager Neil Woodford lagged the wider market again in January. He's also been bargain hu...

Broker Forecast - Beaufort Securities issues a broker note on Horizon Discovery Group Plc

Beaufort Securities today reaffirms its speculative buy investment rating on Horizon Discovery Group Plc (LON:HZD) an...

Additional Listing

RNS Number: 8896W Horizon Discovery Group plc 15 February 2017 15 February 2017 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 2,777 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 2,777 new ordinary shares to be admitted to trading on AIM and it is expe...

Horizon master service deal with top 3 pharma company

Horizon Discovery Group has signed a master services agreement with a top three global pharmaceutical company, extend...

Master Service Agreement with Top 3 Pharma Company

RNS Number: 7719W Horizon Discovery Group plc 14 February 2017 Horizon Discovery Signs a Master Service Agreement with a Top Three Pharmaceutical Company Cambridge, UK, 14 February 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Group"), the world leader in the application of gene editing technologies, today announces the signing o...

Additional Listing

RNS Number: 4783W Horizon Discovery Group plc 10 February 2017 10 February 2017 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 11,306 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 11,306 new ordinary shares to be admitted to trading on AIM and it is expe...

Fundamental DataMore

EPS-11.2
Dividend yield0 %

Latest discussion posts More

  • Director buying

    4 dir + 100,000. Dr Johnathan Milner non ex +90,000. Founder of Abacam & Pharma superstar. Woodford also a holder
    6-Dec-2016
    paul1945
  • Numis

    From Citywire: "?Biologic? era benefits Horizon Discovery, says Numis Gene-editing company Horizon Discovery (HZDH) has improved efficiency and is driving its product ...
    20-Oct-2016
    nk1999
  • CPI partnership

    "An announcement this morning sees Horizon expand the application of its bioproduction cell line platform with new partnerships with the Centre for Process Innovation (CPI, UK) ...
    13-Sep-2016
    Sambram

Users' HoldingsMore

Users who hold Horizon Discovery Group also hold..
LLOYDS GRP.26%
GLAXOSMITHKLINE23%
BP19%
RDS 'B'19%
VODAFONE GRP.18%

Codes & Symbols

ISINGB00BK8FL363
SymbolsHZD, LSE:HZD, HZD.L, HZD:LN, LON:HZD, XLON:HZD